14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KPRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Kiora Pharmaceuticals, Inc. stock price down 2.56% on Monday
(Updated on Apr 15, 2024)

Sell candidate since Apr 12, 2024 Loss -2.56% PDF

The Kiora Pharmaceuticals, Inc. stock price fell by -2.56% on the last day (Monday, 15th Apr 2024) from $0.575 to $0.560. During the last trading day the stock fluctuated 4.98% from a day low at $0.550 to a day high of $0.578. The price has fallen in 6 of the last 10 days and is down by -6.67% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -93 thousand shares and in total, 45 thousand shares were bought and sold for approximately $25.07 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.522 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.14% during the next 3 months and, with a 90% probability hold a price between $0.511 and $0.82 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

KPRX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kiora Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.585 and $0.624. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 01, 2024, and so far it has fallen -34.12%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Kiora Pharmaceuticals, Inc. stock

Kiora Pharmaceuticals, Inc. finds support from accumulated volume at $0.550 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0274 between high and low, or 4.98%. For the last week the stock has had daily average volatility of 8.80%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KPRX) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Kiora Pharmaceuticals, Inc. to open at $0.563, and during the day (based on 14 day Average True Range), to move between $0.509 and $0.611, which gives a possible trading interval of +/-$0.0514 (+/-9.18%) up or down from last closing price. If Kiora Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 18.35% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.550 (1.82%) than the resistance at $0.660 (17.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kiora Pharmaceuticals, Inc. stock A Buy?

Kiora Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.920 Sell Candidate Unchanged

Predicted Opening Price for Kiora Pharmaceuticals, Inc. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$0.563 ( 0.452%) $0.560

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KPRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.590 5.35 %
R2 0.579 3.48 %
R1 0.573 2.32 %
Current price: 0.560
Support S1 0.552 -1.42 %
S2 0.546 -2.57 %
S3 0.535 -4.44 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.694 23.88 %
R2 0.667 19.04 %
R1 0.660 17.86 %
Current price 0.560
Support S1 0.550 -1.82%
S2 0.549 -2.00%
S3 0.548 -2.23%

FAQ

What is the symbol for Kiora Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Kiora Pharmaceuticals, Inc. is KPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Kiora Pharmaceuticals, Inc. Stock?
Kiora Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Kiora Pharmaceuticals, Inc. Stock?
Kiora Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kiora Pharmaceuticals, Inc. Stock.

What's the current price of Kiora Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-04-15, the price of an Kiora Pharmaceuticals, Inc. (KPRX) share was $0.560.

What is the 52-week high and low for Kiora Pharmaceuticals, Inc. Stock?
The 52-week high for Kiora Pharmaceuticals, Inc. Stock is $5.24 and the 52-week low is $0.462.

What is the market capitalization of Kiora Pharmaceuticals, Inc. Stock?
As of the 2024-04-15, the market capitalization of Kiora Pharmaceuticals, Inc. is 14.703M.

When is the next earnings date for Kiora Pharmaceuticals, Inc.?
The upcoming earnings date for Kiora Pharmaceuticals, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals. Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, a... KPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT